Top 8 Alternative Medicine Startups to Watch in 2026
The alternative medicine sector is expanding globally, blending advanced biotechnology with traditional health practices. Companies are emerging from major hubs in the United States, Europe, and China.
This landscape includes heavily funded startups like Orbital Therapeutics, which has secured $270M for its RNA based medicines. Others, like Portugal's AceCann, are focusing on newer areas such as medical cannabis.
Below is our list of 8 Alternative Medicine startups worth keeping an eye on.
Failory's Top 8 Picks
Elektrofi builds drug formulation technology that makes biologic medicines easier to administer. Their proprietary platform concentrates high-dose therapeutics into small-volume injections, offering a subcutaneous alternative to traditional intravenous infusions.
| Headquarters | Boston, Massachusetts, United States |
| Year Founded | 2016 |
| Founders | Chase Coffman |
| Funding Amount | $154.1M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series C |
| Top Investors | National Science Foundation, General Catalyst, RA Capital Management, Catalio Capital Management, Novo Holdings |
Orbital Therapeutics develops RNA-based medicines to treat a wide range of human diseases. They are building a first-of-its-kind platform that integrates established and emerging RNA technologies to expand the scope of therapeutic treatments.
| Headquarters | Cambridge, Massachusetts, United States |
| Year Founded | 2022 |
| Founders | Carol Suh, Drew Weissman, Ph.D, Gene Yeo, Giuseppe Ciaramella, Howard Chang, John Maraganore, Kristina Burow, Ravi Majeti |
| Funding Amount | $270M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series A |
| Top Investors | Andreessen Horowitz, ARCH Venture Partners, Casdin Capital, Redmile Group, Agent Capital |
Scipher Medicine develops a precision immunology platform that analyzes a patient's unique molecular data from a simple blood test. This approach helps determine the most effective drug therapy for individuals with complex autoimmune diseases like rheumatoid arthritis.
| Headquarters | Waltham, Massachusetts, United States |
| Year Founded | 2014 |
| Founders | Albert László Barabasi, Joseph Loscalzo, Marcell Veidner, Peter Ruppert |
| Funding Amount | $227M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series D |
| Top Investors | Alumni Ventures, Khosla Ventures, Hitachi Ventures, Neuberger Berman, Optum Ventures |
They operate a network of clinics and an online platform dedicated to Traditional Chinese Medicine. The platform allows patients to book in-person appointments or receive virtual consultations from its practitioners.
| Headquarters | Guangzhou, Guangdong, China |
| Year Founded | 2010 |
| Founders | Zhiliang Tu |
| Funding Amount | CN¥1B |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series D |
| Top Investors | New Enterprise Associates, Eight Roads Ventures, China Merchants Bank, China Life Insurance, Capital Risk Investment Fund |
Innomedica has created a patented drug delivery system that relies on nanotechnology to target treatments. Their technology is designed to transport active ingredients directly to diseased cells, increasing the efficacy of therapies while reducing side effects.
| Headquarters | Zug, Zug, Switzerland |
| Year Founded | 2000 |
| Founders | Andrea Zurkirchen, Herbert Fruh, Jonas Zeller, Pascal Halbherr, Stefan Halbherr |
| Funding Amount | $39.7M |
| Startup Size | Founding Team (1-10) |
| Last Funding Status | Venture Round |
| Top Investors | — |
AceCann cultivates and processes organic medical cannabis for the pharmaceutical industry. They manage the entire production chain, from research and development to final extraction, to ensure high-quality medicinal products.
| Headquarters | Lisboa, Lisboa, Portugal |
| Year Founded | 2019 |
| Founders | — |
| Funding Amount | $15M |
| Startup Size | Founding Team (1-10) |
| Last Funding Status | Seed |
| Top Investors | Lince Capital, Casa Verde Capital, Frank Cid, Chris Mayle, Sebastian De La Rosa |
RecoveryPlus combines online and offline exercise therapy services to help patients with their physical recovery. The company specializes in creating personalized rehabilitation programs for post-operative care and sports injuries.
| Headquarters | Chengdu, Sichuan, China |
| Year Founded | 2015 |
| Founders | Peter Niemi, Zhen Lei |
| Funding Amount | $21.6M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series B |
| Top Investors | IDG Capital |
Orbsen Therapeutics develops stromal cell immunotherapies to address diseases driven by inflammation and fibrosis. Their work centers on the proprietary ORBCEL™ platform, a technology designed to create a new class of regenerative treatments.
| Headquarters | Galway, Galway, Ireland |
| Year Founded | 2006 |
| Founders | Larry Couture, Stephen Elliman |
| Funding Amount | $1.3M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Venture Round |
| Top Investors | — |
